新华制药(000756) - 2018 Q4 - 年度财报

Financial Performance - The company's operating revenue for 2018 was RMB 5,207,868,838.88, representing a 15.33% increase compared to RMB 4,515,716,784.19 in 2017[15] - The net profit for 2018 reached RMB 274,283,989.92, which is a 23.97% increase from RMB 221,248,751.89 in the previous year[15] - The total assets at the end of 2018 amounted to RMB 5,916,156,319.63, reflecting a 12.18% increase from RMB 5,273,647,124.63 at the end of 2017[15] - The total liabilities increased by 15.79% to RMB 3,119,603,287.55 in 2018, up from RMB 2,694,193,743.82 in 2017[15] - The basic earnings per share for 2018 was RMB 0.40, a 14.29% increase compared to RMB 0.35 in 2017[15] - The net cash flow from operating activities decreased by 11.63% to RMB 344,609,119.10 in 2018, down from RMB 389,971,809.35 in 2017[15] - The company's net assets attributable to shareholders increased by 8.36% to RMB 2,687,248,318.01 at the end of 2018, compared to RMB 2,480,023,776.59 at the end of 2017[15] - The weighted average return on net assets for 2018 was 9.77%, slightly up from 9.70% in 2017[15] - The company reported a significant increase in minority shareholders' profit, which rose by 101.17% to RMB 23,450,564.77 in 2018 from RMB 11,656,844.66 in 2017[15] Shareholder Information - The company plans to distribute a cash dividend of RMB 1 per 10 shares to all shareholders, based on a total of 621,859,447 shares[9] - The total number of shares outstanding as of December 31, 2018, was 621,859,447, an increase from 478,353,421 shares in 2017[23] - The proportion of unrestricted circulating shares was 95.6% of the total shares as of December 31, 2018[23] - The company reported a shareholding increase for Chairman Zhang Daiming due to a capital reserve conversion, with shares rising from 11,900 to 15,470[42] - The company has no disclosed interests or short positions in its shares or bonds by directors, senior management, or supervisors as of December 31, 2018[47] - The company has a total of 10 major unrestricted shareholders, with the top five holding significant stakes[27] Operational Highlights - Total revenue for Q4 2018 was approximately RMB 1.25 billion, showing a slight decline compared to previous quarters[17] - Net profit attributable to shareholders for Q4 2018 was RMB 57.5 million, a decrease from RMB 69.9 million in Q3 2018[17] - The net cash flow from operating activities in Q4 2018 was RMB 201.8 million, a significant improvement from a negative cash flow of RMB 4.1 million in Q3 2018[17] - The company received government subsidies amounting to RMB 22 million in 2018, an increase from RMB 19.1 million in 2017[19] - The company reported a decrease in non-current asset disposal gains, with a loss of RMB 534,277.39 in 2018 compared to a gain of RMB 30.4 million in 2017[19] - The company’s financial assets at fair value decreased to RMB 189.7 million by the end of 2018 from RMB 258.1 million at the beginning of the year[20] Employee and Management Information - The total number of employees in the company is 6,357, with 3,585 in production, 1,096 in sales, and 500 in engineering[52] - In 2018, the company completed 58 training projects, training a total of 3,554 participants, and sent 269 employees for external training[53] - The remuneration for the board of directors in 2018 totaled 416.5 million, with Zhang Daiming receiving 125.8 million and Ren Fulong receiving 96.1 million[49] - The company has a diverse management team with extensive experience in engineering, law, and economics, contributing to its operational effectiveness[40][41] - The company has maintained a consistent leadership structure, with key executives holding their positions for several years, ensuring stability[45] Corporate Governance - The company has established an independent accounting system and financial management policies, ensuring financial independence from the controlling shareholder[63] - The independent auditor provided a standard unqualified opinion on the company's 2018 financial statements, confirming their accuracy and completeness[62] - The company has a robust governance structure with independent supervisors ensuring compliance and oversight[38][40] - The company has established a corporate governance policy in compliance with listing rules, ensuring adherence to legal and regulatory requirements[81] - The board of directors is responsible for creating shareholder value and has clearly defined roles and responsibilities to ensure effective management[88] Research and Development - The company completed 15 key projects throughout the year, significantly enhancing production automation and efficiency[123] - A total of 6 patents were granted, and 23 patents were applied for during the year, reflecting strong R&D efforts[123] - Research and development expenses for 2018 were RMB 186,976 thousand, up 16.01% year-on-year, reflecting increased investment in R&D[139] - The company has established a national-level enterprise technology center and collaborates with over 50 research institutions and universities[162] Environmental Responsibility - The company has been recognized for its commitment to social responsibility, including energy conservation and environmental protection initiatives[199] - The first plant's total chemical oxygen demand (COD) discharge is less than 600 tons/year, while ammonia nitrogen discharge is less than 40 tons/year[200] - The second plant's total COD discharge is less than 500 tons/year, and ammonia nitrogen discharge is less than 20 tons/year[200] - The company adheres to wastewater discharge standards of COD ≤ 500 mg/l and ammonia nitrogen ≤ 45 mg/l[200] - There are no exceedances reported for the emissions[200]